Key facts
- This page summarizes BAXTER INTERNATIONAL INC's Form 4 filing for Miromatrix Medical Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Jun 2021, 17:26.
BAXTER INTERNATIONAL INC - 24 Jun 2021 Form 4 Insider Report for Miromatrix Medical Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 24 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Jun 2021, 17:26:04 UTC
- Prior SEC filing
- 23 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ellen K. Bradford, Senior Vice President & Corporate Secretary
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
BAXTER INTERNATIONAL INC filed Form 4 for Miromatrix Medical Inc. on 25 Jun 2021.
Change
- Previous filing in this sequence was filed on 23 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +2,083,333
- Change %
- Price
- Shares after
- 2,083,333
- Date
- 24 Jun 2021
- Ownership
- See Footnote
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MIRO
transaction
Derivative
Series C Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -2,083,333
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 Jun 2021
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 2,083,333
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Series C Convertible Preferred Stock of Miromatrix Medical Inc. (the "Issuer") were automatically converted into 2,083,333 shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering (the "IPO") of its Common Stock, without payment of consideration. The 2,083,333 shares amount is based on the actual IPO price of $9.00 per share of Common Stock. The 2,343,750 shares amount previously reported on Form 3, dated 06/23/2021, was based on an assumed IPO price of $8.00 per share of Common Stock.
Footnote F2
The reported securities are owned directly by Baxter Healthcare Corporation, a wholly owned subsidiary of Baxter International Inc.